is repatha a glp 1 drug It's been week. And then I get this email. ππ @amgenbiotech who do I need to talk to about this??? Looks like discontinuing their self-injector shot. It's no secret Cholesterol drug decreases incidence of
Description
Certainly, the apparent advantage of tirzepatide, a dual incretin agonist, over GLP-1RA will spark renewed interest in the therapeutic potential of GIP in type 2 diabetes, obesity and related co-morbidities.

Noom is offering 'microdoses' of semaglutide at a knock-down price, claiming they can prevent side effects, but remain effective for weight loss.

Tirzepatide, a novel GLP-1/GIP dual receptor agonist, shows significant advantages in glycemic management and weight control

Learn more: read our full guide to microdosing tirzepatide and the GLP-1 microdosing chart
Here is what the evidence says about protecting your bones and muscle on GLP-1 therapy.

Explore its advantages, side effects, and how it works with Found.